摘要
Byong Seung CHO 医师
博士研究员
The efficacy and safety of ASC-exosomes in androgenetic alopecia based on the translational study including preclinical and clinical study
Objectives: 1. To understand that exosomes derived from adipose stem cells (ASCE) can be a paradigm shift in regenerative aesthetics & therapeutics
2. To demonstrate that ASCE can reduce severe inflammation and improve the barrier reconstruction in skin and scalp
3. To prove that ASCE can make rejuvenate of scalp and prevent hair loss
Introduction: Exosomes are nano-sized (30 - 200 nm in diameter) lipid bilayered vesicles secreted by most cell types. Adipose Stem Cell-derived Exosomes (ASCE) are emerging as a promising cell-free therapy for the treatment of hair loss and scalp rejuvenation. ASCE has been tested for in vitro, in vivo, & clinical studies to prove its efficacy for hair loss. To understand that adipose stem cell exosome (ASCE) can be a paradigm shift in regenerative aesthetics & therapeutics. To know that ASCE can make scalp rejuvenation and hair loss prevention.
Materials / method: ASC-Exosomes were isolated from the serum-free conditioned media by sequential filtration and characterized as recommended by the International Society for Extracellular Vesicles (ISEV). The effects of ASC-exosomes were demonstrated from a variety of in vivo, in vitro, & clinical studies against dermal papilla cells and human hair follicles, in order to show longer hairs and better hair bulb shape. In our clinical study, 29 subjects were treated with microneedling procedure with topical ASCE treatment for 6 months.
Results: ASCE labeled with green fluorescence was easily up-taken by human dermal papilla cells in vitro. ASCE could reduce by up to 20% the level of cellular aging of human dermal papilla cells from UVB irradiation in vitro. ASCE could effectively increase by 10-20 % the length and thickness of human hairs derived from ex vivo human hair follicles for 8 days, which was superior to minoxidil. ASCE-containing formulation showed strong improvement in clinical cases of androgenic alopecia. The ASCE-containing formulation showed the maintenance of the shape of human hair follicles from an ex-vivo study.
Conclusion: ASCE may serve as next-generation technology in terms of regeneration and anti-inflammation for scalp and hair.
披露 - Byong Seung CHO
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2025年 3月 20日 - Recorded during IMCAS World Congress 2025